Biosyent Stock Cash Flow From Operations
| RX Stock | CAD 11.26 0.08 0.71% |
Biosyent fundamentals help investors to digest information that contributes to Biosyent's financial success or failures. It also enables traders to predict the movement of Biosyent Stock. The fundamental analysis module provides a way to measure Biosyent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biosyent stock.
Biosyent | Cash Flow From Operations |
Biosyent Company Cash Flow From Operations Analysis
Biosyent's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Biosyent Cash Flow From Operations | 5.83 M |
Most of Biosyent's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biosyent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Biosyent Cash Flow From Operations Driver Correlations
Understanding the fundamental principles of building solid financial models for Biosyent is extremely important. It helps to project a fair market value of Biosyent Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Biosyent's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Biosyent's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Biosyent's interrelated accounts and indicators.
Click cells to compare fundamentals
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Biosyent has 5.83 M in Cash Flow From Operations. This is 98.9% lower than that of the Pharmaceuticals sector and 98.42% lower than that of the Health Care industry. The cash flow from operations for all Canada stocks is 99.4% higher than that of the company.
Biosyent Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biosyent's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biosyent could also be used in its relative valuation, which is a method of valuing Biosyent by comparing valuation metrics of similar companies.Biosyent is currently under evaluation in cash flow from operations category among its peers.
Biosyent Current Valuation Drivers
We derive many important indicators used in calculating different scores of Biosyent from analyzing Biosyent's financial statements. These drivers represent accounts that assess Biosyent's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Biosyent's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 85.1M | 102.8M | 104.8M | 107.0M | 96.3M | 101.1M | |
| Enterprise Value | 73.5M | 84.2M | 88.3M | 100.2M | 90.2M | 94.7M |
Biosyent Fundamentals
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 114.57 M | ||||
| Shares Outstanding | 11.59 M | ||||
| Shares Owned By Insiders | 33.63 % | ||||
| Shares Owned By Institutions | 1.41 % | ||||
| Number Of Shares Shorted | 357 | ||||
| Price To Earning | 16.61 X | ||||
| Price To Book | 3.50 X | ||||
| Price To Sales | 3.90 X | ||||
| Revenue | 31.59 M | ||||
| Gross Profit | 22.86 M | ||||
| EBITDA | 7.99 M | ||||
| Net Income | 6.46 M | ||||
| Cash And Equivalents | 22.46 M | ||||
| Cash Per Share | 1.59 X | ||||
| Total Debt | 1.22 M | ||||
| Current Ratio | 10.10 X | ||||
| Book Value Per Share | 2.96 X | ||||
| Cash Flow From Operations | 5.83 M | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | 0.60 X | ||||
| Target Price | 11.75 | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 131.94 M | ||||
| Total Asset | 41.53 M | ||||
| Retained Earnings | 27.53 M | ||||
| Working Capital | 30.34 M | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 41.53 M |
About Biosyent Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biosyent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biosyent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biosyent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.